Healthcare company-building profile
Office of Therapeutics Alliances
NYU Langone Health / NYU Grossman School of Medicine
AcceleratorUniversity acceleratorUniversityActive
Source-based profile
Program at a Glance
- Program type
- Accelerator
- Program category
- University accelerator
- Organization
- NYU Langone Health / NYU Grossman School of Medicine
- Organization type
- University
- Location
- New York, New York
- Company stage served
- Research or idea stage to Early stage
- Cohort or participation model
- Project-based internal funding and development support rather than fixed cohorts
- Investment or funding offered
- Not publicly documented
- Published investment terms
- Not publicly documented
- Equity or fee model
- Not publicly documented
- Clinical or hospital connection
- Not publicly documented
- Application status
- Active
Public description
About the program
The Office of Therapeutics Alliances is NYU's internal drug-discovery accelerator, supplying funding and a continuum of resources for early-stage therapeutic programs arising from NYU research. It gives academic investigators access to medicinal chemistry, pharmacology, pharmacokinetics and toxicology expertise plus external development partners. The office sits within NYU's Office of Science and Research and works to make emerging assets attractive to established and startup biopharma partners.
What the program publicly emphasizes
Focus areas and features
Drug discoverytherapeuticsmedicinal chemistrypharmacologybiopharma partnering
- Category: University accelerator
- Program structure: Project-based internal funding and development support rather than fixed cohorts
Sources
External source links open in a new tab.